Mining FDA drug labels using an unsupervised learning technique - topic modeling
<p>Abstract</p> <p>Background</p> <p>The Food and Drug Administration (FDA) approved drug labels contain a broad array of information, ranging from adverse drug reactions (ADRs) to drug efficacy, risk-benefit consideration, and more. However, the labeling language used...
Main Authors: | Xu Xiaowei, Fang Hong, Liu Zhichao, Bisgin Halil, Tong Weida |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | BMC Bioinformatics |
Similar Items
-
Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA
by: Leihong Wu, et al.
Published: (2019-03-01) -
ArrayTrack: a free FDA bioinformatics tool to support emerging biomedical research -- an update
by: Xu Joshua, et al.
Published: (2010-08-01) -
Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)
by: Jeeyun A. Kim, et al.
Published: (2021-03-01) -
DLI-IT: a deep learning approach to drug label identification through image and text embedding
by: Xiangwen Liu, et al.
Published: (2020-04-01) -
Evaluation of Bioinformatics Approaches for Next-Generation Sequencing Analysis of microRNAs with a Toxicogenomics Study Design
by: Halil Bisgin, et al.
Published: (2018-02-01)